DEVICE CATEGORY · PZJ
Lynch Syndrome Test System
The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
VENTANA MMR IHC PanelK260776 | Roche Tissue Diagnostics, Inc. | 510(k) clearance | Oct 23, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
